Document is current
Any future updates will be listed below
-
Authors
Ivory, Joannie https://orcid.org/0000-0003-3646-1178
Wheeler, Stephanie B.
Drier, Sarah
Gunn, Heather
Zahrieh, David
Paskett, Electra
Naughton, Michelle
Wills, Rachel
Swetel, Kayla
Chow, Selina
Reeder-Hayes, Katherine
-
Funding
Funding for this research was provided by:
National Cancer Institute (U10CA180882-09, UG1CA18923-09, UG1CA233327, UG1CA233373, UG1CA233331, R01CA237357)
NCORP (U10CA180821, UG1CA189823)
- License Information
-
More Information
Article History
Received: 23 June 2023
Accepted: 25 September 2023
First Online: 12 October 2023
Declarations
:
: We have obtained informed consent from all participants in the study. Current human protection committee approval of this protocol and a consent form is required prior to patient consent and registration. In addition, all participating sites must obtain approval through the NCI Central Institutional Review Board prior to opening the study.
: A template for informed consent form is attached as .
: Joannie Ivory is a consultant for Clinical Congress Consultants.Katherine Reeder-Hayes and Stephanie Wheeler receive grant funding paid to their institution by the Pfizer Medical Foundation.David Zahrieh is currently an employee at Ultragenyx Pharmaceutical Inc. This work, however, is not sponsored by Ultragenyx.Electra Paskett has grant funding to the institution not related to this study from Pfizer, Merck Foundation, Genentech, and Guardant Health.The other authors declare that they have no competing interests.
